Robert Wood Johnson Foundation

FDA increases enforcement, policy steps against unproven stem cell therapies

Friday, September 1, 2017

Scott Gottlieb, M.D., the Commissioner of the FDA, has stated that the agency is beginning to enforce stricter and more aggressive tactics against stem cell clinics who are marketing and administrating unproven therapies to patients. The administration will work toward cracking down on companies who claim to have cures or treatments for diseases that have no conclusive clinical efficacy.

[Read More]

Search for the next FDA commissioner offers wide-ranging temperament of styles

Monday, February 6, 2017

President Trump—as he has done with other cabinet and agency picks—is keeping Congress and the public guessing about his choice for the next FDA Commissioner. Possible candidates to succeed outgoing Commissioner Dr. Robert Califf range from a severe critic of the FDA who advocates disbanding the agency to a policy conservative but defender of the FDA. 

[Read More]